{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T17:58:21Z","timestamp":1781027901354,"version":"3.54.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1054195"],"award-info":[{"award-number":["1054195"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1037304"],"award-info":[{"award-number":["1037304"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12916-017-0888-3","type":"journal-article","created":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T13:52:56Z","timestamp":1501595576000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["The clinical utility of the urine-based lateral flow lipoarabinomannan assay in HIV-infected adults in Myanmar: an observational study"],"prefix":"10.1186","volume":"15","author":[{"given":"Swe Swe","family":"Thit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ne Myo","family":"Aung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaw Win","family":"Htet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Htin Aung","family":"Saw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas M.","family":"Anstey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tint Tint","family":"Kyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar Mar","family":"Kyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,4]]},"reference":[{"issue":"15","key":"888_CR1","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1097\/QAD.0000000000000802","volume":"29","author":"RK Gupta","year":"2015","unstructured":"Gupta RK, Lucas SB, Fielding KL, Lawn SD. Prevalence of tuberculosis in post-mortem studies of HIV-infected adults and children in resource-limited settings: a systematic review and meta-analysis. AIDS. 2015;29(15):1987\u20132002.","journal-title":"AIDS"},{"key":"888_CR2","volume-title":"Global Tuberculosis Report 2016","author":"World Health Organization","year":"2016","unstructured":"World Health Organization. Global Tuberculosis Report 2016. Geneva: WHO; 2016."},{"key":"888_CR3","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12981-016-0106-y","volume":"13","author":"W Manosuthi","year":"2016","unstructured":"Manosuthi W, Wiboonchutikul S, Sungkanuparph S. Integrated therapy for HIV and tuberculosis. AIDS Res Ther. 2016;13:22.","journal-title":"AIDS Res Ther."},{"key":"888_CR4","first-page":"CD011420","volume":"5","author":"M Shah","year":"2016","unstructured":"Shah M, Hanrahan C, Wang ZY, Dendukuri N, Lawn SD, Denkinger CM, Steingart KR. Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults. Cochrane Database Syst Rev. 2016;5:CD011420.","journal-title":"Cochrane Database Syst Rev."},{"issue":"5","key":"888_CR5","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S1473-3099(03)00609-1","volume":"3","author":"K Siddiqi","year":"2003","unstructured":"Siddiqi K, Lambert ML, Walley J. Clinical diagnosis of smear-negative pulmonary tuberculosis in low-income countries: the current evidence. Lancet Infect Dis. 2003;3(5):288\u201396.","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"888_CR6","doi-asserted-by":"crossref","first-page":"e450","DOI":"10.1016\/S2214-109X(15)00100-X","volume":"3","author":"GJ Churchyard","year":"2015","unstructured":"Churchyard GJ, Stevens WS, Mametja LD, McCarthy KM, Chihota V, Nicol MP, Erasmus LK, Ndjeka NO, Mvusi L, Vassall A, et al. Xpert MTB\/RIF versus sputum microscopy as the initial diagnostic test for tuberculosis: a cluster-randomised trial embedded in South African roll-out of Xpert MTB\/RIF. Lancet Glob Health. 2015;3(8):e450\u2013457.","journal-title":"Lancet Glob Health"},{"issue":"9915","key":"888_CR7","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0140-6736(13)62073-5","volume":"383","author":"G Theron","year":"2014","unstructured":"Theron G, Zijenah L, Chanda D, Clowes P, Rachow A, Lesosky M, Bara W, Mungofa S, Pai M, Hoelscher M, et al. Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB\/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial. Lancet. 2014;383(9915):424\u201335.","journal-title":"Lancet"},{"key":"888_CR8","volume-title":"Xpert MTB\/RIF implementation manual: technical and operational \u2018how-to\u2019; practical considerations","author":"World Health Organization","year":"2014","unstructured":"World Health Organization. Xpert MTB\/RIF implementation manual: technical and operational \u2018how-to\u2019; practical considerations. Geneva: WHO; 2014."},{"issue":"10024","key":"888_CR9","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0140-6736(16)00146-X","volume":"387","author":"AD Kerkhoff","year":"2016","unstructured":"Kerkhoff AD, Lawn SD. A breakthrough urine-based diagnostic test for HIV-associated tuberculosis. Lancet. 2016;387(10024):1139\u201341.","journal-title":"Lancet"},{"key":"888_CR10","volume-title":"The use of lateral flow urine lipoarabinomannan assay (LF-LAM) for the diagnosis and screening of active tuberculosis in people living with HIV","author":"World Health Organization","year":"2015","unstructured":"World Health Organization. The use of lateral flow urine lipoarabinomannan assay (LF-LAM) for the diagnosis and screening of active tuberculosis in people living with HIV. Geneva: WHO; 2015."},{"key":"888_CR11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/1741-7015-11-231","volume":"11","author":"SD Lawn","year":"2013","unstructured":"Lawn SD, Kerkhoff AD, Vogt M, Wood R. HIV-associated tuberculosis: relationship between disease severity and the sensitivity of new sputum-based and urine-based diagnostic assays. BMC Med. 2013;11:231.","journal-title":"BMC Med."},{"issue":"18","key":"888_CR12","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1097\/QAD.0000000000000008","volume":"27","author":"M Shah","year":"2013","unstructured":"Shah M, Dowdy D, Joloba M, Ssengooba W, Manabe YC, Ellner J, Dorman SE. Cost-effectiveness of novel algorithms for rapid diagnosis of tuberculosis in HIV-infected individuals in Uganda. AIDS. 2013;27(18):2883\u201392.","journal-title":"AIDS"},{"issue":"4","key":"888_CR13","doi-asserted-by":"crossref","first-page":"552","DOI":"10.5588\/ijtld.12.0627","volume":"17","author":"D Sun","year":"2013","unstructured":"Sun D, Dorman S, Shah M, Manabe YC, Moodley VM, Nicol MP, Dowdy DW. Cost utility of lateral-flow urine lipoarabinomannan for tuberculosis diagnosis in HIV-infected African adults. Int J Tuberc Lung Dis. 2013;17(4):552\u20138.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"10024","key":"888_CR14","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0140-6736(15)01092-2","volume":"387","author":"JG Peter","year":"2016","unstructured":"Peter JG, Zijenah LS, Chanda D, Clowes P, Lesosky M, Gina P, Mehta N, Calligaro G, Lombard CJ, Kadzirange G, et al. Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trial. Lancet. 2016;387(10024):1187\u201397.","journal-title":"Lancet"},{"issue":"8","key":"888_CR15","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1056\/NEJMoa0907488","volume":"362","author":"KP Cain","year":"2010","unstructured":"Cain KP, McCarthy KD, Heilig CM, Monkongdee P, Tasaneeyapan T, Kanara N, Kimerling ME, Chheng P, Thai S, Sar B, et al. An algorithm for tuberculosis screening and diagnosis in people with HIV. N Engl J Med. 2010;362(8):707\u201316.","journal-title":"N Engl J Med"},{"issue":"5","key":"888_CR16","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2217\/fmb.12.34","volume":"7","author":"S Swaminathan","year":"2012","unstructured":"Swaminathan S, Rekha VV. Antigen detection as a point-of-care test for TB: the case of lipoarabinomannan. Future Microbiol. 2012;7(5):559\u201364.","journal-title":"Future Microbiol"},{"issue":"2","key":"888_CR17","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0377-1237(11)60038-5","volume":"67","author":"L Singh","year":"2011","unstructured":"Singh L, Grover N. Detection of TB antigen by rapid test kit. Med J Armed Forces India. 2011;67(2):196\u20137.","journal-title":"Med J Armed Forces India"},{"key":"888_CR18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12916-016-0603-9","volume":"14","author":"A Gupta-Wright","year":"2016","unstructured":"Gupta-Wright A, Peters JA, Flach C, Lawn SD. Detection of lipoarabinomannan (LAM) in urine is an independent predictor of mortality risk in patients receiving treatment for HIV-associated tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis. BMC Med. 2016;14:53.","journal-title":"BMC Med."},{"issue":"12 Suppl","key":"888_CR19","first-page":"S17","volume":"8","author":"S Banoo","year":"2010","unstructured":"Banoo S, Bell D, Bossuyt P, Herring A, Mabey D, Poole F, Smith PG, Sriram N, Wongsrichanalai C, Linke R, et al. Evaluation of diagnostic tests for infectious diseases: general principles. Nat Rev Microbiol. 2010;8(12 Suppl):S17\u201329.","journal-title":"Nat Rev Microbiol"},{"key":"888_CR20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1471-2334-12-103","volume":"12","author":"SD Lawn","year":"2012","unstructured":"Lawn SD. Point-of-care detection of lipoarabinomannan (LAM) in urine for diagnosis of HIV-associated tuberculosis: a state of the art review. BMC Infect Dis. 2012;12:103.","journal-title":"BMC Infect Dis."},{"issue":"5","key":"888_CR21","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1183\/09031936.00201711","volume":"40","author":"JG Peter","year":"2012","unstructured":"Peter JG, Theron G, van Zyl-Smit R, Haripersad A, Mottay L, Kraus S, Binder A, Meldau R, Hardy A, Dheda K. Diagnostic accuracy of a urine lipoarabinomannan strip-test for TB detection in HIV-infected hospitalised patients. Eur Respir J. 2012;40(5):1211\u201320.","journal-title":"Eur Respir J"},{"key":"888_CR22","unstructured":"HIV and AIDS Estimates, Myanmar. http:\/\/www.unaids.org\/en\/regionscountries\/countries\/myanmar . Accessed 18 Jan 2017."},{"issue":"2","key":"888_CR23","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00002030-200101260-00002","volume":"15","author":"YD Mukadi","year":"2001","unstructured":"Mukadi YD, Maher D, Harries A. Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa. AIDS. 2001;15(2):143\u201352.","journal-title":"AIDS"},{"issue":"11","key":"888_CR24","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1164\/rccm.200206-626OC","volume":"167","author":"D Yee","year":"2003","unstructured":"Yee D, Valiquette C, Pelletier M, Parisien I, Rocher I, Menzies D. Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis. Am J Respir Crit Care Med. 2003;167(11):1472\u20137.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"888_CR25","first-page":"287","volume":"15","author":"SD Lawn","year":"2011","unstructured":"Lawn SD, Ayles H, Egwaga S, Williams B, Mukadi YD, Santos Filho ED, Godfrey-Faussett P, Granich RM, Harries AD. Potential utility of empirical tuberculosis treatment for HIV-infected patients with advanced immunodeficiency in high TB-HIV burden settings. Int J Tuberc Lung Dis. 2011;15(3):287\u201395.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"2","key":"888_CR26","doi-asserted-by":"crossref","first-page":"111","DOI":"10.5588\/pha.16.0009","volume":"6","author":"AM Thi","year":"2016","unstructured":"Thi AM, Shewade HD, Kyaw NT, Oo MM, Aung TK, Aung ST, Oo HN, Win T, Harries AD. Timing of antiretroviral therapy and TB treatment outcomes in patients with TB-HIV in Myanmar. Public Health Action. 2016;6(2):111\u20137.","journal-title":"Public Health Action"},{"issue":"9","key":"888_CR27","doi-asserted-by":"crossref","first-page":"e108615","DOI":"10.1371\/journal.pone.0108615","volume":"9","author":"A Thida","year":"2014","unstructured":"Thida A, Tun ST, Zaw SK, Lover AA, Cavailler P, Chunn J, Aye MM, Par P, Naing KW, Zan KN, et al. Retention and risk factors for attrition in a large public health ART program in Myanmar: a retrospective cohort analysis. PLoS One. 2014;9(9):e108615.","journal-title":"PLoS One"},{"issue":"1","key":"888_CR28","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12981-017-0137-z","volume":"14","author":"NM Aung","year":"2017","unstructured":"Aung NM, Hanson J, Kyi TT, Htet ZW, Cooper DA, Boyd MA, Kyi MM, Saw HA. HIV care in Yangon, Myanmar; successes, challenges and implications for policy. AIDS Res Ther. 2017;14(1):10.","journal-title":"AIDS Res Ther"},{"key":"888_CR29","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12916-017-0822-8","volume":"15","author":"SD Lawn","year":"2017","unstructured":"Lawn SD, Kerkhoff AD, Burton R, Schutz C, Boulle A, Vogt M, Gupta-Wright A, Nicol MP, Meintjes G. Diagnostic accuracy, incremental yield and prognostic value of Determine TB-LAM for routine diagnostic testing for tuberculosis in HIV-infected patients requiring acute hospital admission in South Africa: a prospective cohort. BMC Med. 2017;15:67.","journal-title":"BMC Med."},{"issue":"5","key":"888_CR30","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1128\/JCM.23.5.901-904.1986","volume":"23","author":"GV Kadival","year":"1986","unstructured":"Kadival GV, Mazarelo TB, Chaparas SD. Sensitivity and specificity of enzyme-linked immunosorbent assay in the detection of antigen in tuberculous meningitis cerebrospinal fluids. J Clin Microbiol. 1986;23(5):901\u20134.","journal-title":"J Clin Microbiol"},{"key":"888_CR31","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix513","author":"JS Nel","year":"2017","unstructured":"Nel JS, Lippincott CK, Berhanu R, Spencer DC, Sanne IM, Ive P. Does disseminated nontuberculous mycobacterial disease cause false-positive Determine B-LAM lateral flow assay results? A retrospective review. Clin Infect Dis. 2017. doi: 10.1093\/cid\/cix513 .","journal-title":"Clin Infect Dis"},{"issue":"Suppl 5","key":"888_CR32","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1097\/01.aids.0000391023.03037.1f","volume":"24","author":"H Getahun","year":"2010","unstructured":"Getahun H, Granich R, Sculier D, Gunneberg C, Blanc L, Nunn P, Raviglione M. Implementation of isoniazid preventive therapy for people living with HIV worldwide: barriers and solutions. AIDS. 2010;24 Suppl 5:S57\u201365.","journal-title":"AIDS."},{"key":"888_CR33","unstructured":"National AIDS Programme, Ministry of Health: Global AIDS Response Progress Report Myanmar. Nay Pyi Taw: Republic of the Union of Myanmar: National AIDS Programme, Ministry of Health; 2015."},{"issue":"9777","key":"888_CR34","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/S0140-6736(11)60204-3","volume":"377","author":"T Samandari","year":"2011","unstructured":"Samandari T, Agizew TB, Nyirenda S, Tedla Z, Sibanda T, Shang N, Mosimaneotsile B, Motsamai OI, Bozeman L, Davis MK, et al. 6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial. Lancet. 2011;377(9777):1588\u201398.","journal-title":"Lancet"},{"issue":"9","key":"888_CR35","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJMoa1507198","volume":"373","author":"C Danel","year":"2015","unstructured":"Danel C, Moh R, Gabillard D, Badje A, Le Carrou J, Ouassa T, Ouattara E, Anzian A, Ntakpe JB, Minga A, et al. A trial of early antiretrovirals and isoniazid preventive therapy in Africa. N Engl J Med. 2015;373(9):808\u201322.","journal-title":"N Engl J Med"},{"key":"888_CR36","volume-title":"Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings","author":"World Health Organization","year":"2011","unstructured":"World Health Organization. Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings. Geneva: WHO; 2011."},{"issue":"2","key":"888_CR37","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/COH.0000000000000345","volume":"12","author":"L Scott","year":"2017","unstructured":"Scott L, da Silva P, Boehme CC, Stevens W, Gilpin CM. Diagnosis of opportunistic infections: HIV co-infections - tuberculosis. Curr Opin HIV AIDS. 2017;12(2):129\u201338.","journal-title":"Curr Opin HIV AIDS"},{"issue":"1","key":"888_CR38","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1473-3099(14)71049-7","volume":"15","author":"SD Lawn","year":"2015","unstructured":"Lawn SD, Nicol MP, Corbett EL. Effect of empirical treatment on outcomes of clinical trials of diagnostic assays for tuberculosis. Lancet Infect Dis. 2015;15(1):17\u20138.","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"888_CR39","doi-asserted-by":"crossref","first-page":"363","DOI":"10.4103\/0253-7613.81494","volume":"43","author":"R Kumar","year":"2011","unstructured":"Kumar R. Empirical use of antituberculosis drugs should not be equated to their inappropriate and indiscriminate use. Indian J Pharmacol. 2011;43(3):363\u20134.","journal-title":"Indian J Pharmacol"},{"issue":"15","key":"888_CR40","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1097\/QAD.0b013e32830007cd","volume":"22","author":"SD Lawn","year":"2008","unstructured":"Lawn SD, Harries AD, Anglaret X, Myer L, Wood R. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS. 2008;22(15):1897\u2013908.","journal-title":"AIDS"},{"issue":"4","key":"888_CR41","doi-asserted-by":"crossref","first-page":"e1000066","DOI":"10.1371\/journal.pmed.1000066","volume":"6","author":"MW Brinkhof","year":"2009","unstructured":"Brinkhof MW, Boulle A, Weigel R, Messou E, Mathers C, Orrell C, Dabis F, Pascoe M, Egger M. Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality. PLoS Med. 2009;6(4):e1000066.","journal-title":"PLoS Med"},{"issue":"1","key":"888_CR42","first-page":"7","volume":"23","author":"D Bachani","year":"2010","unstructured":"Bachani D, Garg R, Rewari BB, Hegg L, Rajasekaran S, Deshpande A, Emmanuel KV, Chan P, Rao KS. Two-year treatment outcomes of patients enrolled in India\u2019s national first-line antiretroviral therapy programme. Natl Med J India. 2010;23(1):7\u201312.","journal-title":"Natl Med J India"},{"issue":"1","key":"888_CR43","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/QAI.0b013e31824bd33f","volume":"60","author":"F Fregonese","year":"2012","unstructured":"Fregonese F, Collins IJ, Jourdain G, Lecoeur S, Cressey TR, Ngo-Giang-Houng N, Banchongkit S, Chutanunta A, Techapornroong M, Lallemant M. Predictors of 5-year mortality in HIV-infected adults starting highly active antiretroviral therapy in Thailand. J Acquir Immune Defic Syndr. 2012;60(1):91\u20138.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"888_CR44","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/QAD.0b013e328321823f","volume":"23","author":"SD Lawn","year":"2009","unstructured":"Lawn SD, Little F, Bekker LG, Kaplan R, Campbel E, Orrell C, Wood R. Changing mortality risk associated with CD4 cell response to antiretroviral therapy in South Africa. AIDS. 2009;23(3):335\u201342.","journal-title":"AIDS"},{"issue":"12","key":"888_CR45","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/01.aids.0000238406.93249.cd","volume":"20","author":"SD Lawn","year":"2006","unstructured":"Lawn SD, Myer L, Bekker LG, Wood R. Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control. AIDS. 2006;20(12):1605\u201312.","journal-title":"AIDS"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-017-0888-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T00:11:03Z","timestamp":1602634263000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-017-0888-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,4]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["888"],"URL":"https:\/\/doi.org\/10.1186\/s12916-017-0888-3","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,4]]},"article-number":"145"}}